ApoM-Fc engineered fusion protein (Boston Children's Hospital)

N/A

Report date: 2025/03/17 09:42:35

Base Information

Drug NameApoM-Fc engineered fusion protein (Boston Children's Hospital)
Drug Alias NameApolipoprotein M-Fc engineered fusion protein (Boston Children's Hospital)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionSphingosine 1-Phosphate Receptor 1 agonists
TargetsSphingosine 1-Phosphate Receptor 1
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Children's Hospital Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCardiovascular Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A